Adult stem cell research continues apace. This PR press release touts an Australian company’s gaining FDA approval to conduct human experiments in treating heart disease with adult stem cells. It’s a “Phase 2 Trial,” meaning it tests efficacy as well as safety. From the release:
The Phase 2 clinical trial will be based at the Texas Heart Institute,and will follow a similar protocol to the one used by the same investigators in preclinical studies for the IND submission. These showed that implantation of the company’s proprietary allogeneic stem cells by catheter into damaged heart muscle resulted in significant improvement inheart function and reduction in congestive heart failure.
This clinical trial will be the first to test an allogeneic stem cell product injected by catheter into heart muscle damaged by a recent heart attack.
Of course, most of the release is about the business aspect of all this. Life sciences: thy name is commerce.
YOU MIGHT ALSO LIKE
The Church in the Age of Therapy
In 1966, Philip Rieff wrote in The Triumph of the Therapeutic that “Religious man was born to…
Canada’s Deadliest Blind Spot
On September 20, the Daily Mail ran a story with the provocative headline, “Our 83-year-old Christian grandmother…
The Faithful Joy of Dolly Parton and Fulton Sheen
Dolly Parton and Fulton Sheen seem to have had little in common. She favored rhinestones; he wore…
